Velmanase Alfa

ATC A16AB15 · 4 markets · 4 records

Velmanase Alfa 4 markets · 4 records Forms

GB 1 records · 1 strengths

10 mginjectionLamzede 10mg powder for solution for infusion vials also in AU

AU 1 records · 1 strengths

10 mginjectionLAMZEDE velmanase alfa 10 mg powder for injection vial also in GB unknown

HK 1 records · 1 strengths

Records without a stated strength · 1 LAMZEDE POWDER FOR SOLUTION FOR INFUSION 10MG/VIAL

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Lamzede

Side-by-side table

Strength / form / release	GB	AU	HK	EU
10 mg injection	Lamzede 10mg powder for solution for infusion vials	LAMZEDE velmanase alfa 10 mg powder for injection vial	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	LAMZEDE POWDER FOR SOLUTION FOR INFUSION 10MG/VIAL	Lamzede

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.